Stock exchange
Medical technology provider Brainlab canceled the IPO
The medical technology company Brainlab, founded in 1989, is no longer a start-up, but an established size in its industry. The planned passage to the stock exchange does not run according to schedule.
The Munich medical technology manufacturer Brainlab surprisingly canceled its IPO two days before the planned first trading day on the Frankfurt stock exchange. The company did not give reasons. A second attempt at a later point in time is not excluded: “A later time will continue to be checked by Brainlab and the selling shareholders,” said the capital market in the short duty.
High tech showcase company
The second planned IPO of a company in Frankfurt has burst within a week. Last week the Berlin car replacement dealer Autodoc had already canceled his IPO.
Brainlab was founded in 1989 and employs almost 1,800 people. Among other things, the company develops planning software for surgeons and radiotherapists. In German politics, the company has long been a showcase address for a high tech company. At the opening of today’s company headquarters in the tower of the former Munich airport in 2017, the then Chancellor Angela Merkel (CDU) held the speech.
Offer period has been running for a week
The offer period for the Brainlab shares has been running since June 24, and the first day of trading was the 3rd July. The offer included two million new shares from a capital increase and up to 3.2 million secondary stocks from the existence of the alta shareholders, including company founders and supervisory board chief Stefan Vilsmeier. The price range should be between 80 and 100 euros. The company had hoped for a market capitalization of 1.67 to 2.09 billion euros.
dpa
Source: Stern
